Isoform- and Cell Type-Specific Roles of Glycogen Synthase Kinase 3 N-Terminal Serine Phosphorylation in Liver Ischemia Reperfusion Injury.

The Journal of Immunology : Official Journal of the American Association of Immunologists
Ming NiYuan Zhai

Abstract

Glycogen synthase kinase 3 (Gsk3) α and β are both constitutively active and inhibited upon stimulation by N-terminal serine phosphorylation. Although roles of active Gsk3 in liver ischemia reperfusion injury (IRI) have been well appreciated, whether Gsk3 N-terminal serine phosphorylation has any functional significance in the disease process remains unclear. In a murine liver partial warm ischemia model, we studied Gsk3 N-terminal serine mutant knock-in (KI) mice and showed that liver IRI was decreased in Gsk3αS21A but increased in Gsk3βS9A mutant KI mice. Bone marrow chimeric experiments revealed that the Gsk3α, but not β, mutation in liver parenchyma protected from IRI, and both mutations in bone marrow-derived cells exacerbated liver injuries. Mechanistically, mutant Gsk3α protected hepatocytes from inflammatory (TNF-α) cell death by the activation of HIV-1 TAT-interactive protein 60 (TIP60)-mediated autophagy pathway. The pharmacological inhibition of TIP60 or autophagy diminished the protection of the Gsk3α mutant hepatocytes from inflammatory cell death in vitro and the Gsk3α mutant KI mice from liver IRI in vivo. Thus, Gsk3 N-terminal serine phosphorylation inhibits liver innate immune activation but suppresses hepatocy...Continue Reading

References

Jan 10, 2002·Gastroenterology·Hannes A Rüdiger, Pierre-Alain Clavien
Jan 10, 2002·Proceedings of the National Academy of Sciences of the United States of America·Christopher L AntosEric N Olson
Jun 18, 2002·American Journal of Physiology. Gastrointestinal and Liver Physiology·Robert F Schwabe, David A Brenner
May 7, 2003·Proceedings of the National Academy of Sciences of the United States of America·Ming RenDe-Maw Chuang
Feb 10, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Narci TeohGeoffrey Farrell
Jun 3, 2004·Nature Reviews. Drug Discovery·Philip Cohen, Michel Goedert
Dec 9, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yuan ZhaiJerzy W Kupiec-Weglinski
Nov 23, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Allan TsungTimothy R Billiar
Oct 3, 2007·Cell Metabolism·Katrina MacAulayJames R Woodgett
Nov 29, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yuan ZhaiJerzy W Kupiec-Weglinski
Dec 25, 2008·Proceedings of the National Academy of Sciences of the United States of America·Takahisa MatsudaJunichi Sadoshima
Jun 6, 2009·Journal of the American Society of Nephrology : JASN·Gilbert R KinseyMark D Okusa
Jun 6, 2009·Circulation Research·Magdalena JuhaszovaSteven J Sollott
Oct 20, 2009·Trends in Immunology·Eléonore BeurelRichard S Jope
Feb 13, 2010·Annual Review of Physiology·Roberta A Gottlieb, Robert M Mentzer
Jun 1, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Heidi MenradBernhard Brüne
Aug 11, 2010·Journal of Molecular and Cellular Cardiology·Ian G WebbMichael S Marber
Jan 15, 2011·Cardiovascular Research·François VigneronBéatrice Jaspard-Vinassa
May 14, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Feng RenYuan Zhai
Jun 15, 2011·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Y ZhaiJ W Kupiec-Weglinski
Nov 24, 2011·Frontiers in Molecular Neuroscience·Oksana Kaidanovich-Beilin, James Robert Woodgett
Oct 12, 2012·PloS One·Kelly CoffeyCraig N Robson
Jan 22, 2013·Cell Communication and Signaling : CCS·Karla Lh FeijsBernhard Lüscher
Feb 2, 2013·Biochimica Et Biophysica Acta·Limor AvrahamiHagit Eldar-Finkelman
Apr 4, 2013·The Journal of Clinical Investigation·Jibin ZhouThomas Force
Jul 3, 2013·Proceedings of the National Academy of Sciences of the United States of America·Sonja C StadlerC David Allis
Apr 29, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Shi YueYuan Zhai
Jun 21, 2014·Scientific Reports·Chunxia GaoJames A L Brown
Nov 2, 2014·Nature Reviews. Drug Discovery·Holger K EltzschigSean P Colgan
Dec 2, 2014·Pharmacology & Therapeutics·Eleonore BeurelRichard S Jope
Jan 2, 2015·Circulation Research·Hind LalThomas Force

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
X FangG B Mills
Oxidative Medicine and Cellular Longevity
Romina MancinelliClaudia Giampietri
European Journal of Medicinal Chemistry
Fabio Lo MonteBoris Schmidt
The International Journal of Biochemistry & Cell Biology
Miriam S GiambellucaMarc Pouliot
© 2021 Meta ULC. All rights reserved